Clinical trial
Baricitinib Curative Repression of HIV-1
NCT07209267 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Baricitinib Curative Repression of HIV-1
- Lead sponsor
- Emory University
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- October 31, 2026
- Completion date
- January 31, 2028
- Enrollment
- 35 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hiv, hiv infection